Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Agilent Technologies Inc. announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1 billion market and strong demand for the company’s high-quality active ...
read more
Wednesday, January 31, 2018
Agilent Technologies announced a partnership with Science Exchange, an enterprise platform for outsourced research and development services.
read more
Agilent Technologies announced it has acquired Oxfordshire, U.K.-based Cobalt Light Systems, a provider of highly differentiated Raman spectroscopic instruments for the pharmaceutical industry, applied markets and public safety.
read more
Wednesday, August 10, 2016
Agilent Technologies Inc. has acquired 20 acres in Weld County, Colorado, on which it plans to build a pharmaceutical manufacturing facility.
The expansion will enable the company to more than double its commercial manufacturing capacity for nucleic...
read more
Agilent Technologies has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion.
read more
Agilent Technologies Inc. announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and manufacturing organization, for $925 million.
read more
Wednesday, March 06, 2019
Agilent Technologies and Imperial College London have announced that several state-of-the-art analytical instruments have been installed into the college’s Molecular Sciences Research Hub.
read more
Agno Pharma, a CDMO specializing in small-molecule active pharmaceutical ingredients (APIs) and critical GMP intermediates announced the acquisition of Actylis Eugene, the legacy Cascade Chemistry business based in Eugene, Oregon.
read more
Monday, December 18, 2023
Agno Pharma, a US-based, contract development and manufacturing organization, announced that it will acquire the Lubrizol Particle Sciences Inc. business. The acquisition includes the drug product formulation technology behind the Particle Sciences ...
read more
AGU Planungsgesellschaft mbH and TetraScience have announced a new partnership to integrate their flagship products to automatically collect and unify R&D data in life sciences.
read more
AI VIVO is seeking pharma and biotech collaboration partners to progress therapeutic candidates that have been identified by the Company as “top-ranked” for COVID-19.
read more
Monday, September 12, 2022
AiCure, an artificial intelligence (AI) and advanced data analytics has announced the launch of its clinical site services offering. The new program provides sites with end-to-end, customized support and monitoring of metrics related to adherence, ...
read more
Wednesday, February 24, 2021
AiCure and OncoBay Clinical announced a partnership to provide oncology sponsors with scalable, AI-powered insights to improve patient care and optimize drug development.
read more
Wednesday, April 22, 2020
AIkido Pharma announced the Company executed a Master License Agreement with the University of Maryland, Baltimore.
read more
Wednesday, January 10, 2018
Aimmune Therapeutics announced an expansion and extension of its exclusive supply agreement with Golden Peanut and Tree Nuts, to support AR101.
read more